A detailed history of Nicholas Hoffman & Company, Llc. transactions in Abbott Laboratories stock. As of the latest transaction made, Nicholas Hoffman & Company, Llc. holds 11,421 shares of ABT stock, worth $1.34 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
11,421
Previous 11,407 0.12%
Holding current value
$1.34 Million
Previous $1.19 Million 9.87%
% of portfolio
0.06%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$100.07 - $118.13 $1,400 - $1,653
14 Added 0.12%
11,421 $1.3 Million
Q2 2024

Aug 02, 2024

SELL
$100.73 - $112.44 $14,102 - $15,741
-140 Reduced 1.21%
11,407 $1.19 Million
Q1 2024

Apr 22, 2024

SELL
$109.52 - $120.96 $245,324 - $270,950
-2,240 Reduced 16.25%
11,547 $1.31 Million
Q4 2023

Jan 31, 2024

BUY
$90.19 - $110.4 $34,001 - $41,620
377 Added 2.81%
13,787 $1.52 Million
Q3 2023

Nov 06, 2023

SELL
$95.53 - $114.62 $13,374 - $16,046
-140 Reduced 1.03%
13,410 $1.3 Million
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $26,202 - $29,195
260 Added 1.96%
13,550 $1.48 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $22,858 - $26,906
236 Added 1.81%
13,290 $1.35 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $1,901 - $2,230
20 Added 0.15%
13,054 $1.43 Million
Q3 2022

Nov 04, 2022

BUY
$96.76 - $112.03 $50,508 - $58,479
522 Added 4.17%
13,034 $1.26 Million
Q2 2022

Aug 09, 2022

BUY
$102.07 - $123.37 $44,196 - $53,419
433 Added 3.58%
12,512 $1.36 Million
Q1 2022

May 10, 2022

BUY
$114.02 - $139.04 $3,306 - $4,032
29 Added 0.24%
12,079 $1.43 Million
Q4 2021

Feb 10, 2022

BUY
$115.53 - $141.46 $43,785 - $53,613
379 Added 3.25%
12,050 $1.7 Million
Q3 2021

Nov 04, 2021

SELL
$116.66 - $129.06 $1,749 - $1,935
-15 Reduced 0.13%
11,671 $1.38 Million
Q2 2021

Aug 10, 2021

BUY
$105.79 - $124.53 $150,644 - $177,330
1,424 Added 13.88%
11,686 $1.36 Million
Q1 2021

May 11, 2021

BUY
$108.84 - $128.23 $15,999 - $18,849
147 Added 1.45%
10,262 $1.23 Million
Q4 2020

Feb 11, 2021

SELL
$105.0 - $114.42 $52,605 - $57,324
-501 Reduced 4.72%
10,115 $1.11 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $3,757 - $4,562
41 Added 0.39%
10,616 $1.16 Million
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $51,531 - $65,954
-673 Reduced 5.98%
10,575 $967,000
Q1 2020

May 11, 2020

BUY
$62.82 - $91.86 $107,547 - $157,264
1,712 Added 17.95%
11,248 $888,000
Q4 2019

Feb 12, 2020

BUY
$78.51 - $87.4 $5,809 - $6,467
74 Added 0.78%
9,536 $828,000
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $3,191 - $3,460
-39 Reduced 0.41%
9,462 $792,000
Q2 2019

Aug 12, 2019

SELL
$72.88 - $85.0 $3,935 - $4,590
-54 Reduced 0.57%
9,501 $799,000
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $4,171 - $5,043
63 Added 0.66%
9,555 $764,000
Q4 2018

Feb 08, 2019

BUY
$65.56 - $74.27 $91,456 - $103,606
1,395 Added 17.23%
9,492 $687,000
Q3 2018

Nov 09, 2018

BUY
$60.81 - $73.36 $250,658 - $302,389
4,122 Added 103.7%
8,097 $594,000
Q2 2018

Aug 07, 2018

BUY
$57.57 - $63.54 $16,292 - $17,981
283 Added 7.67%
3,975 $242,000
Q1 2018

May 07, 2018

BUY
$56.27 - $63.62 $207,748 - $234,885
3,692 New
3,692 $221,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Nicholas Hoffman & Company, Llc. Portfolio

Follow Nicholas Hoffman & Company, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Hoffman & Company, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Hoffman & Company, Llc. with notifications on news.